methotrexate 2.5mg tablets
a a h pharmaceuticals ltd - methotrexate - oral tablet - 2.5mg
methotrexate 2.5mg tablets
advanz pharma - methotrexate - oral tablet - 2.5mg
methotrexate 2.5mg tablets
pfizer healthcare ireland - methotrexate - tablet - 2.5 milligram(s) - other immunosuppressants; methotrexate
methotrexate injection bp solution
accord healthcare inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents
methotrexate injection, bp solution
pharmascience inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents
methotrexate injection bp solution
accord healthcare inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents
methotrexate injection bp solution
accord healthcare inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents
methotrexate injection bp solution
accord healthcare inc - methotrexate (methotrexate sodium) - solution - 25mg - methotrexate (methotrexate sodium) 25mg - antineoplastic agents
methoblastin methotrexate 2.5mg tablet bottle
pfizer australia pty ltd - methotrexate, quantity: 2.5 mg - tablet, uncoated - excipient ingredients: magnesium stearate; maize starch; lactose monohydrate; polysorbate 80; microcrystalline cellulose; pregelatinised maize starch - antineoplastic chemotherapy: treatment of breast cancer, gestational choriocarcinoma, and in patients with chorioadenoma destruens and hydatidiform mole. palliation of acute and subacute lymphocytic leukaemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukaemias. in combination with corticosteroids, methotrexate may be used for induction of remission. the drug is now most commonly used for the maintenance of induced remissions. methoblastin is also effective in the treatment of the advanced stages (iii and iv, peters staging system) of lymphosarcoma, particularly in children and in advanced cases of mycosis fungoides. psoriasis chemotherapy: (see warnings box and precautions). because of the high risk attending to its use, methoblastin is only indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatolo
methotrexate solution
pfizer canada ulc - methotrexate - solution - 25mg - methotrexate 25mg - antineoplastic agents